Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Ocular tissue LC-MS/MS bioanalysis laboratory services supporting ocular drugs preclinical or clinical development
Intertek's ocular tissue LC-MS/MS bioanalysis experience extends over a decade in regard to development and highly optimised validation for a wide variety of compounds in multiple ocular matrices of different species which adhere closely to regulated bioanalysis guidance.
A diverse platform of homogenization and extraction techniques is available for processing ocular tissues and fluids to ensure optimal recovery of analytes. Technologies such as multi-tube bead homogenization and high energy ultrasonication are often employed individually, or in conjunction with more traditional processing techniques.
Non-GLP studies are also routinely conducted to support discovery, lead optimization and proof of concept programs of ocular drugs.
Methods have been validated in the following ocular matrices:
Need help or have a question?